PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
19.35%
Positive revenue growth while MRVL is negative. John Neff might see a notable competitive edge here.
14.31%
Positive gross profit growth while MRVL is negative. John Neff would see a clear operational edge over the competitor.
22.75%
Positive EBIT growth while MRVL is negative. John Neff might see a substantial edge in operational management.
22.75%
Positive operating income growth while MRVL is negative. John Neff might view this as a competitive edge in operations.
22.78%
Positive net income growth while MRVL is negative. John Neff might see a big relative performance advantage.
19.05%
Positive EPS growth while MRVL is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
21.62%
Positive diluted EPS growth while MRVL is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.64%
Share count expansion well above MRVL's 0.21%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.39%
Slight or no buyback while MRVL is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
1601.67%
Positive OCF growth while MRVL is negative. John Neff would see this as a clear operational advantage vs. the competitor.
8479.93%
Positive FCF growth while MRVL is negative. John Neff would see a strong competitive edge in net cash generation.
465.05%
10Y revenue/share CAGR at 50-75% of MRVL's 679.29%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
81.02%
5Y revenue/share CAGR under 50% of MRVL's 456.51%. Michael Burry would suspect a significant competitive gap or product weakness.
54.70%
3Y revenue/share CAGR under 50% of MRVL's 109.78%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
1740.46%
10Y OCF/share CAGR in line with MRVL's 1751.49%. Walter Schloss would see both as similarly efficient over the decade.
1114.11%
Below 50% of MRVL's 18720.53%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
3177.45%
3Y OCF/share CAGR above 1.5x MRVL's 254.73%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
571.17%
Net income/share CAGR above 1.5x MRVL's 82.34% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
94.79%
5Y net income/share CAGR similar to MRVL's 104.50%. Walter Schloss might see both on parallel mid-term trajectories.
1435.61%
Positive short-term CAGR while MRVL is negative. John Neff would see a clear advantage in near-term profit trajectory.
1152.88%
10Y equity/share CAGR in line with MRVL's 1194.79%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
146.87%
5Y equity/share CAGR above 1.5x MRVL's 25.30%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
67.51%
3Y equity/share CAGR above 1.5x MRVL's 34.92%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-4.43%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-1.35%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
15.90%
Asset growth above 1.5x MRVL's 2.00%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
10.85%
BV/share growth above 1.5x MRVL's 1.40%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
No Data
No Data available this quarter, please select a different quarter.
10.59%
R&D growth drastically higher vs. MRVL's 0.19%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
9.47%
SG&A declining or stable vs. MRVL's 32.81%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.